Black Diamond Therapeutics Target Price

Black Diamond Therapeutics target price — quarterly history, peer benchmarks, and growth trends.

Get informed when a big investor buys or sells

+ Follow

Share Price

$2.02

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-01-16	Piper SandlerKelsey Goodwin	$8	296% upside
2025-10-15	Stifel NicolausLaura Prendergast	$8	296% upside
2025-09-03	GuggenheimBrad Canino	$8	296% upside
2024-07-31	Raymond JamesLaura Prendergast	$20	890.1% upside
2024-06-03	Piper SandlerJoseph Calanzaro	$12	494.1% upside
2024-05-16	H.C. WainwrightRobert Burns	$11	444.6% upside
2024-04-08	WedbushRobert Driscoll	$16	692.1% upside
2024-03-18	H.C. WainwrightRaghuram Selvaraju	$12	494.1% upside

Black Diamond Therapeutics (BDTX) FAQ

Stockcircle tracks target price for Black Diamond Therapeutics (BDTX), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Black Diamond Therapeutics's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main BDTX overview so you can move from this figure to the surrounding analysis quickly.